SLDB: Solid Biosciences Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Solid Biosciences Inc (SLDB).
$159.82M Market Cap.
SLDB Market Cap. (MRY)
SLDB Shares Outstanding (MRY)
SLDB Assets (MRY)
Total Assets
$188.66M
Total Liabilities
$51.42M
Total Investments
$70.64M
SLDB Income (MRY)
Revenue
$0
Net Income
-$124.70M
Operating Expense
$129.73M
SLDB Cash Flow (MRY)
CF Operations
-$100.01M
CF Investing
-$16.09M
CF Financing
$122.44M
SLDB Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $188,662,000 (14.38%) | $164,939,000 (-36.62%) | $260,252,000 (11.99%) | $232,380,000 (35.76%) |
Assets Current | $157,302,000 (21.25%) | $129,734,000 (-40.93%) | $219,638,000 (-1.34%) | $222,612,000 (40.09%) |
Assets Non-Current | $31,360,000 (-10.92%) | $35,205,000 (-13.32%) | $40,614,000 (315.79%) | $9,768,000 (-20.38%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $137,246,000 (8.51%) | $126,481,000 (-40.25%) | $211,666,000 (1.66%) | $208,211,000 (57.63%) |
Property Plant & Equipment Net | $29,042,000 (-12.43%) | $33,163,000 (-14.10%) | $38,606,000 (407.71%) | $7,604,000 (-35.19%) |
Cash & Equivalents | $80,235,000 (5.78%) | $75,848,000 (-51.76%) | $157,217,000 (29.71%) | $121,206,000 (-21.84%) |
Accumulated Other Comprehensive Income | $47,000 (213.33%) | $15,000 (122.06%) | -$68,000 (-51.11%) | -$45,000 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $8,080,000 (-61.00%) |
Total Investments | $70,637,000 (42.34%) | $49,625,000 (-14.94%) | $58,338,000 (-34.19%) | $88,643,000 (0%) |
Investments Current | $68,685,000 (38.41%) | $49,625,000 (-14.94%) | $58,338,000 (-34.19%) | $88,643,000 (0%) |
Investments Non-Current | $1,952,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $110,000 (0%) |
Trade & Non-Trade Payables | $4,237,000 (108.51%) | $2,032,000 (-37.25%) | $3,238,000 (-27.45%) | $4,463,000 (36.32%) |
Accumulated Retained Earnings (Deficit) | -$783,450,000 (-18.93%) | -$658,753,000 (-17.06%) | -$562,738,000 (-18.03%) | -$476,757,000 (-17.84%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $24,177,000 (-7.95%) | $26,265,000 (-7.99%) | $28,547,000 (1283.76%) | $2,063,000 (-59.95%) |
Debt Current | $3,018,000 (29.86%) | $2,324,000 (-9.40%) | $2,565,000 (71.57%) | $1,495,000 (-32.26%) |
Debt Non-Current | $21,159,000 (-11.62%) | $23,941,000 (-7.86%) | $25,982,000 (4474.30%) | $568,000 (-80.71%) |
Total Liabilities | $51,416,000 (33.69%) | $38,458,000 (-20.85%) | $48,586,000 (101.03%) | $24,169,000 (-38.16%) |
Liabilities Current | $30,257,000 (108.42%) | $14,517,000 (-35.50%) | $22,508,000 (-4.63%) | $23,601,000 (-3.59%) |
Liabilities Non-Current | $21,159,000 (-11.62%) | $23,941,000 (-8.19%) | $26,078,000 (4491.20%) | $568,000 (-96.11%) |
SLDB Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $8,094,000 (-40.57%) | $13,620,000 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $33,297,000 (19.98%) | $27,752,000 (-4.13%) | $28,948,000 (6.68%) | $27,135,000 (25.74%) |
Research & Development Expense | $96,431,000 (25.95%) | $76,563,000 (-2.37%) | $78,420,000 (33.51%) | $58,739,000 (-9.47%) |
Operating Expenses | $129,728,000 (24.44%) | $104,252,000 (-8.99%) | $114,546,000 (33.39%) | $85,874,000 (-2.86%) |
Interest Expense | $340,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$124,697,000 (-29.87%) | -$96,015,000 (-11.67%) | -$85,981,000 (-19.11%) | -$72,188,000 (18.24%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$124,697,000 (-29.87%) | -$96,015,000 (-11.67%) | -$85,981,000 (-19.11%) | -$72,188,000 (18.24%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$124,697,000 (-29.87%) | -$96,015,000 (-11.67%) | -$85,981,000 (-19.11%) | -$72,188,000 (18.24%) |
Weighted Average Shares | $40,816,694 (105.27%) | $19,884,007 (133.60%) | $8,512,089 (19.58%) | $7,118,024 (105.58%) |
Weighted Average Shares Diluted | $40,816,694 (105.27%) | $19,884,007 (133.60%) | $8,512,089 (19.58%) | $7,118,024 (105.58%) |
Earning Before Interest & Taxes (EBIT) | -$124,357,000 (-29.52%) | -$96,015,000 (-11.67%) | -$85,981,000 (-19.11%) | -$72,188,000 (18.24%) |
Gross Profit | $0 (0%) | $0 (0%) | $8,094,000 (-40.57%) | $13,620,000 (0%) |
Operating Income | -$129,728,000 (-24.44%) | -$104,252,000 (2.07%) | -$106,452,000 (-47.33%) | -$72,254,000 (18.27%) |
SLDB Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$16,086,000 (-266.02%) | $9,689,000 (-83.62%) | $59,157,000 (164.95%) | -$91,086,000 (-1480.09%) |
Net Cash Flow from Financing | $122,437,000 (3821.75%) | $3,122,000 (-95.83%) | $74,831,000 (-44.56%) | $134,985,000 (4.88%) |
Net Cash Flow from Operations | -$100,012,000 (-6.19%) | -$94,180,000 (3.88%) | -$97,977,000 (-25.99%) | -$77,764,000 (-37.39%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $6,339,000 (107.79%) | -$81,369,000 (-325.96%) | $36,011,000 (206.34%) | -$33,865,000 (-143.03%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $31,523,000 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$15,437,000 (-237.78%) | $11,204,000 (-62.71%) | $30,049,000 (133.46%) | -$89,805,000 (-1297.56%) |
Capital Expenditure | -$649,000 (57.16%) | -$1,515,000 (37.27%) | -$2,415,000 (-88.52%) | -$1,281,000 (-42.49%) |
Issuance (Repayment) of Debt Securities | -$473,000 (0%) | $0 (0%) | $2,077,000 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $122,910,000 (3836.90%) | $3,122,000 (-95.71%) | $72,732,000 (-46.12%) | $134,985,000 (1.88%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $10,519,000 (37.95%) | $7,625,000 (1.17%) | $7,537,000 (-43.64%) | $13,373,000 (15.00%) |
Depreciation Amortization & Accretion | $4,846,000 (87.76%) | $2,581,000 (7.18%) | $2,408,000 (-18.76%) | $2,964,000 (-24.43%) |
SLDB Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | 100.00% (0.00%) | 100.00% |
Profit Margin | - | - | -1062.30% (-100.43%) | -530.00% |
EBITDA Margin | - | - | -1032.50% (-103.13%) | -508.30% |
Return on Average Equity (ROAE) | -70.40% (-13.37%) | -62.10% (-26.99%) | -48.90% (-56.23%) | -31.30% (77.71%) |
Return on Average Assets (ROAA) | -56.70% (-15.71%) | -49.00% (-22.50%) | -40.00% (-42.86%) | -28.00% (72.76%) |
Return on Sales (ROS) | - | - | -1062.30% (-100.43%) | -530.00% |
Return on Invested Capital (ROIC) | -92.40% (-5.60%) | -87.50% (-17.61%) | -74.40% (34.91%) | -114.30% (91.13%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.31 (-2.83%) | -1.27 (-138.46%) | -0.53 (79.41%) | -2.59 (41.94%) |
Price to Sales Ratio (P/S) | - | - | 5.66 (-58.76%) | 13.72 |
Price to Book Ratio (P/B) | 1.16 (18.78%) | 0.98 (410.42%) | 0.19 (-79.29%) | 0.93 (-73.28%) |
Debt to Equity Ratio (D/E) | 0.38 (23.36%) | 0.3 (32.17%) | 0.23 (98.28%) | 0.12 (-60.81%) |
Earnings Per Share (EPS) | -3.06 (36.65%) | -4.83 (52.18%) | -10.1 (0.39%) | -10.14 (60.24%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0.95 (-50.29%) | 1.91 (0%) |
Free Cash Flow Per Share (FCFPS) | -2.47 (48.76%) | -4.81 (59.19%) | -11.79 (-6.20%) | -11.11 (33.13%) |
Book Value Per Share (BVPS) | 3.36 (-47.15%) | 6.36 (-74.42%) | 24.87 (-14.99%) | 29.25 (-23.32%) |
Tangible Assets Book Value Per Share (TABVPS) | 4.62 (-44.28%) | 8.29 (-72.87%) | 30.57 (-6.35%) | 32.65 (-33.96%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (0.00%) | -1 (0%) | 0 (0%) | -1 (80.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1 (5.99%) | -1.07 (-480.98%) | -0.18 (85.10%) | -1.24 (76.25%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0.04 (-28.30%) | 0.05 (0%) |
Current Ratio | 5.2 (-41.83%) | 8.94 (-8.41%) | 9.76 (3.46%) | 9.43 (45.31%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$100,661,000 (-5.19%) | -$95,695,000 (4.68%) | -$100,392,000 (-27.01%) | -$79,045,000 (-37.47%) |
Enterprise Value (EV) | $120,143,428 (20.31%) | $99,860,482 (549.85%) | $15,366,719 (-82.03%) | $85,525,300 (-80.51%) |
Earnings Before Tax (EBT) | -$124,697,000 (-29.87%) | -$96,015,000 (-11.67%) | -$85,981,000 (-19.11%) | -$72,188,000 (18.24%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$119,511,000 (-27.91%) | -$93,434,000 (-11.80%) | -$83,573,000 (-20.73%) | -$69,224,000 (17.95%) |
Invested Capital | $102,347,000 (1.50%) | $100,839,000 (-7.55%) | $109,074,000 (21.69%) | $89,636,000 (2874.25%) |
Working Capital | $127,045,000 (10.27%) | $115,217,000 (-41.55%) | $197,130,000 (-0.95%) | $199,011,000 (48.05%) |
Tangible Asset Value | $188,662,000 (14.38%) | $164,939,000 (-36.62%) | $260,252,000 (11.99%) | $232,380,000 (35.76%) |
Market Capitalization | $159,818,428 (29.00%) | $123,889,482 (205.62%) | $40,537,719 (-79.00%) | $193,017,300 (-57.88%) |
Average Equity | $177,059,250 (14.54%) | $154,589,250 (-12.00%) | $175,671,750 (-23.83%) | $230,628,000 (266.82%) |
Average Assets | $220,039,500 (12.27%) | $195,994,000 (-8.92%) | $215,194,500 (-16.63%) | $258,125,500 (200.49%) |
Invested Capital Average | $134,534,750 (22.54%) | $109,788,500 (-5.03%) | $115,598,000 (83.08%) | $63,142,250 (821.75%) |
Shares | 39,954,607 (98.02%) | 20,177,440 (167.79%) | 7,534,892 (2.47%) | 7,353,077 (82.46%) |
